Abstract
Gastro intestinal stromal tumors (GIST) are non-epithelial tumors of gastrointestinal tract (GIT) arising from mesenchymal cells and interstitial cells of Cajal. It accounts for <1% of all of gastro-intestinal (GI) tumors and <5% of all GI malignancies. GIST most commonly involves stomach and small intestine, but rarely involves mesentery. Surgical resection is the main stay of treatment. Post-operative use of imatinib, delays the recurrence and improves the survival rate. In our study, we report a case of mesenteric GIST, a very rare entity and discuss the course of clinical presentation, diagnosis, management and prognosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
